CKD-581 Downregulates Wnt/ß-Catenin Pathway by DACT3 Induction in Hematologic Malignancy.

Kim, Soo Jin; Kim, Suntae; Choi, Yong June; Kim, U Ji; Kang, Keon Wook

Kim, Soo Jin; Kim, Suntae; Choi, Yong June; Kim, U Ji; Kang, Keon Wook.

Afiliação

Kim SJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Kim S; CKD Research Institution, Chong Kun Dang Pharmaceutical Corporation, Yongin 16995, Republic of Korea.
Choi YJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Kim UJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Kang KW; CKD Research Institution, Chong Kun Dang Pharmaceutical Corporation, Yongin 16995, Republic of Korea.

Biomol Ther (Seoul) ; 30(5): 435-446, 2022 Sep 01.

Article em En | MEDLINE | ID: mdl-35794797

Palavras-chave

CKD-581; DACT3; HDAC; Hematologic cancer; Wnt/ß-catenin pathway

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Biomol Ther (Seoul) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google